Facebook
Twitter
Telegram
Report an ErrorSyndax Pharmaceuticals Financial Statements 2011-2024 | SNDX
Annual Financial Statements Syndax Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.72 B | 1.55 B | 812 M | 1.01 B | 203 M | 139 M | 236 M | 110 M | - | - | - | - | - |
Shares |
70.4 M | 60.8 M | 52.1 M | 41.3 M | 30.5 M | 25.4 M | 21 M | 14.6 M | - | - | - | - | - |
Historical Prices |
24.5 | 25.6 | 15.6 | 24.4 | 9.41 | 6.17 | 9.04 | 11.4 | - | - | - | - | - |
Net Income |
-209 M | -149 M | 24.9 M | -73.2 M | -56 M | -74 M | -60.8 M | -44.5 M | -24.1 M | -19.8 M | -14.2 M | -9.96 M | - |
Revenue |
- | - | 140 M | 1.52 M | 1.52 M | 1.52 M | 2.11 M | 1.22 M | 627 K | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | 627 K | - | - | - | - |
Operating Income |
-230 M | -152 M | 26.2 M | -71.4 M | -57.5 M | -75.9 M | -62 M | -43.8 M | -20.5 M | -21.3 M | - | - | - |
Interest Expense |
208 K | 3.14 M | 1.9 M | 2.36 M | -79 K | -27 K | -269 K | 41 K | -37 K | 4 K | - | - | - |
EBITDA |
-218 M | -119 M | 69.2 M | -71.3 M | -57.4 M | -75.8 M | -61.9 M | -43.7 M | -20.5 M | -23.1 M | -6.74 M | -12.1 M | - |
Operating Expenses |
230 M | 152 M | 113 M | 72.9 M | 59.1 M | 77.4 M | 64.1 M | 45 M | 21.1 M | - | - | - | - |
General and Administrative Expenses |
66.9 M | 33.3 M | 25.2 M | 22.5 M | 16.1 M | 17.3 M | 15.9 M | 13.3 M | 11.6 M | 11.2 M | 5.36 M | 3.49 M | - |
All numbers in USD currency
Quarterly Income Statement Syndax Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
85.2 M | 84.8 M | 69.9 M | 69.6 M | 69.4 M | 68.1 M | 60.7 M | 60.2 M | 59 M | 55 M | 52 M | 51.6 M | 51.5 M | 46.1 M | 44.2 M | 40.6 M | 34.3 M | 31.6 M | 31.6 M | 31.6 M | 27 M | 26.8 M | 25.5 M | 24.7 M | 24.5 M | 23.9 M | 22.2 M | 19.5 M | 18.2 M | 18.2 M | 17.9 M | 17.8 M | 4.54 M | 83.2 K | 71.6 K | 59.8 K | 58.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-72.4 M | - | -51.1 M | -44.6 M | -41.1 M | - | -35.4 M | -37.6 M | -37.2 M | - | -20.6 M | -22.9 M | -27.7 M | -20.4 M | -20.4 M | -17.1 M | -15.2 M | -14 M | -12.8 M | -14.9 M | -14.3 M | -18.8 M | -17.3 M | -18.4 M | -19.4 M | -19.1 M | -15.1 M | -13.6 M | -13 M | -10.8 M | -15 M | -8.36 M | -10.3 M | -5.26 M | -7.73 M | -6.21 M | -4.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | 12.4 M | 379 K | 379 K | 380 K | 379 K | 379 K | 379 K | 380 K | 379 K | 379 K | 379 K | 380 K | 379 K | 379 K | 379 K | 1.19 M | 305 K | 305 K | 305 K | - | 305 K | 305 K | 305 K | - | 305 K | 17 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-79.5 M | - | -56.4 M | -49.7 M | -46 M | - | -35.1 M | -37.7 M | -36.9 M | - | -20 M | -22.3 M | -27.2 M | -19.9 M | -19.9 M | -16.6 M | -15.1 M | -14.2 M | -13.1 M | -15.4 M | -14.8 M | -19.3 M | -17.8 M | -19 M | -19.8 M | -19.5 M | -15.4 M | -13.8 M | -13.2 M | -11.1 M | -15.2 M | -8.63 M | -8.75 M | -4.68 M | -5.86 M | -5.54 M | -4.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
55 K | - | 70 K | 35 K | 40 K | - | 1.75 M | 695 K | 651 K | - | 649 K | 634 K | 623 K | - | 635 K | 638 K | 449 K | - | -75 K | -43 K | 57 K | - | 15 K | 104 K | -122 K | - | -53 K | -87 K | -53 K | - | 1 K | -18 K | -18 K | - | -37 K | -4 K | -6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | -35.1 M | -37.7 M | -36.9 M | - | -20 M | -22.3 M | -27.2 M | -19.9 M | -19.9 M | -16.6 M | -15.1 M | -14.2 M | -13.1 M | -15.4 M | -15 M | -19.3 M | -18.1 M | -19.1 M | -19.8 M | -19.5 M | -15.2 M | -13.8 M | -13.2 M | -11.1 M | -15.2 M | -8.58 M | -8.7 M | -4.68 M | -5.4 M | -5.28 M | -4.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
79.5 M | - | 56.4 M | 49.7 M | 46 M | - | 35.1 M | 37.7 M | 36.9 M | - | 32.4 M | 22.7 M | 27.5 M | 20.2 M | 20.2 M | 17 M | 15.5 M | 14.6 M | 13.5 M | 15.8 M | 15.2 M | 19.7 M | 18.2 M | 19.3 M | 20.1 M | 20.7 M | 15.8 M | 14.1 M | 13.5 M | 11.4 M | 15.5 M | 8.94 M | 9.06 M | 4.98 M | 6.16 M | 5.56 M | 4.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
23 M | - | 17.3 M | 14.9 M | 12 M | - | 8.24 M | 7.99 M | 6.84 M | - | 6.8 M | 5.84 M | 5.67 M | 4.72 M | 5.82 M | 6.05 M | 5.92 M | 5.08 M | 3.6 M | 3.46 M | 3.91 M | 3.89 M | 4.12 M | 4.48 M | 4.79 M | 4.08 M | 3.56 M | 4.28 M | 3.93 M | 2.97 M | 3.27 M | 2.81 M | 4.27 M | 2.4 M | 3.2 M | 3.29 M | 2.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency